KLK3 and Familial prostate cancer: Unique when compared to previous studies, participants in the study by Kindermann et al. [24] were selected on the basis of having a high baseline PSA, without evidence of prostate cancer on biopsy, and this higher baseline seems to have had an impact on the magnitude of the increase and proportion of men demonstrating an increase in PSA.